Literature DB >> 1630637

Narcolepsy.

M S Aldrich1.   

Abstract

Narcolepsy is a chronic neurologic disorder characterized by excessive daytime sleepiness, cataplexy, and premature onset of rapid eye movement sleep. It can be differentiated from other disorders causing daytime drowsiness by its clinical symptoms and by sleep laboratory studies. The disorder usually begins in adolescence and remains present throughout life. Genetic susceptibility to narcolepsy is closely associated with specific HLAs that indicate the existence of a gene in the region of the major histocompatibility complex on chromosome 6 that increases susceptibility to narcolepsy. Neurochemical studies of human and canine narcolepsy have demonstrated disturbed monoaminergic and cholinergic function that may account for impaired regulation of rapid eye movement sleep, but the link between these abnormalities and the genetic factors is still unknown. Treatment of sleepiness with stimulants and cataplexy with tricyclic antidepressants leads to substantial improvement but does not fully resolve symptoms in most patients.

Entities:  

Mesh:

Year:  1992        PMID: 1630637

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  Lesson of the week: Narcolepsy mistaken for epilepsy.

Authors:  A Zeman; N Douglas; R Aylward
Journal:  BMJ       Date:  2001-01-27

Review 2.  Narcolepsy in children: a practical guide to its diagnosis, treatment and follow-up.

Authors:  C Guilleminault; R Pelayo
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

3.  Relationship between antral distension and postprandial symptoms in functional dyspepsia.

Authors:  Nadia Pallotta; Patrizio Pezzotti; Enrico Corazziari
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

Review 4.  Genetics of narcolepsy and other sleep disorders.

Authors:  E Mignot
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 5.  Sleep disorders in school-age children.

Authors:  S Kotagal
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

6.  Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy.

Authors:  S Nishino; J Arrigoni; J Shelton; T Kanbayashi; W C Dement; E Mignot
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

7.  Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.

Authors:  K J McClellan; C M Spencer
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

8.  Identification of the variations in the CPT1B and CHKB genes along with the HLA-DQB1*06:02 allele in Turkish narcolepsy patients and healthy persons.

Authors:  Sultan Cingoz; Sinem Agilkaya; Ibrahim Oztura; Secil Eroglu; Derya Karadeniz; Ahmet Evlice; Oguz Altungoz; Hikmet Yilmaz; Baris Baklan
Journal:  Genet Test Mol Biomarkers       Date:  2014-02-26

9.  CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.

Authors:  Y Dauvilliers; C R Baumann; B Carlander; M Bischof; T Blatter; M Lecendreux; F Maly; A Besset; J Touchon; M Billiard; M Tafti; C L Bassetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 10.  Narcolepsy in the older adult: epidemiology, diagnosis and management.

Authors:  Sangeeta S Chakravorty; David B Rye
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.